A detailed history of Kathmere Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 18,204 shares of NVO stock, worth $2.59 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
18,204
Previous 20,764 12.33%
Holding current value
$2.59 Million
Previous $2.67 Million 2.55%
% of portfolio
0.33%
Previous 0.31%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 01, 2024

SELL
$122.71 - $146.91 $314,137 - $376,089
-2,560 Reduced 12.33%
18,204 $2.6 Million
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $261,401 - $347,955
2,560 Added 14.06%
20,764 $2.67 Million
Q4 2023

Apr 16, 2024

SELL
$87.78 - $105.45 $6,320 - $7,592
-72 Reduced 0.39%
18,204 $1.88 Million
Q3 2023

Oct 11, 2023

BUY
$90.94 - $199.54 $920,312 - $2.02 Million
10,120 Added 124.08%
18,276 $1.66 Million
Q2 2023

Jul 11, 2023

BUY
$155.98 - $172.65 $8,734 - $9,668
56 Added 0.69%
8,156 $1.32 Million
Q1 2023

Apr 20, 2023

BUY
$132.34 - $159.14 $142,794 - $171,712
1,079 Added 15.37%
8,100 $1.29 Million
Q4 2022

Jan 24, 2023

SELL
$102.55 - $135.33 $28,201 - $37,215
-275 Reduced 3.77%
7,021 $0
Q4 2022

Jan 24, 2023

BUY
$102.55 - $135.33 $144,800 - $191,085
1,412 Added 24.0%
7,296 $0
Q3 2022

Oct 11, 2022

BUY
$95.28 - $116.93 $161,118 - $197,728
1,691 Added 40.33%
5,884 $586,000
Q2 2022

Aug 09, 2022

BUY
$103.24 - $121.81 $203,486 - $240,087
1,971 Added 88.7%
4,193 $467,000
Q1 2022

Apr 28, 2022

BUY
$93.1 - $112.54 $206,868 - $250,063
2,222 New
2,222 $247,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kathmere Capital Management, LLC Portfolio

Follow Kathmere Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.